Related Experiment Video
Updated: Aug 7, 2026

Cost-Efficient Transcriptomic-Based Drug Screening
Published on: February 23, 2024
Genomic approaches to drug discovery
Darrell O Ricke1, Shaowen Wang, Richard Cai
1Novartis Institutes for BioMedical Research, Inc., 250 Massachusetts Avenue, Cambridge, MA 02139, USA.
Genomic and genetic data, alongside advanced tools, are crucial for identifying novel drug targets. Investigating pathways, microRNAs, and epigenetics offers new therapeutic strategies and patient stratification opportunities.
Area of Science:
- Genomics
- Molecular Biology
- Pharmacology
Background:
- Genomic and genetic information offer vast potential for drug discovery.
- New bioinformatics tools are essential for analyzing complex biological data.
- Understanding signaling pathways is key to identifying disease mechanisms.
Purpose of the Study:
- To highlight advancements in utilizing genomic data for drug target identification.
- To showcase novel tools for analyzing gene expression and pathway differences.
- To emphasize the role of microRNAs and epigenetics in therapeutic development.
Main Methods:
- Gene expression data mining with pathway information.
- High-throughput forward and reverse genetics.
- Analysis of microRNA regulatory functions.
- Integration of epigenetic data (DNA methylation, histone modifications).
Main Results:
- Identification of potential drug targets through genomic and genetic approaches.
- Characterization of pathway differences in normal versus disease states.
- Discovery of microRNAs' regulatory roles in biological processes.
- Leveraging epigenetic modifications for novel therapeutic strategies.
Conclusions:
- Genomic and genetic insights are pivotal for advancing drug discovery and development.
- Sophisticated tools are necessary for exploring the genome and identifying therapeutic targets.
- Epigenetic information expands possibilities for personalized medicine and novel drug development.
More Related Videos
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
09:33Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
Published on: August 25, 2023
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Drug Discovery: Overview
Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Principles of Pharmacogenetics: Types of Genetic Variants